Clinical Trial
A clinical trial with glipizide - a relative new sulphonylurea
- PMID: 398642
Item in Clipboard
Clinical Trial
A clinical trial with glipizide - a relative new sulphonylurea
Med J Zambia.
1978 Aug-Sep.
Abstract
Glipizide is a relatively new sulphonylurea- antidiabetic agent. 24 maturity-onset diabetics were studied to determine the dosage required to produce adequate control and the safety and tolerance of the drug. It was concluded that glipizide is a safe and potent anti-diabetic agent and a suitable alternative in those patients poorly-controlled on standard oral hypoglycaemic drugs.
Similar articles
-
Clinical trial with glipizide in uncomplicated maturity onset diabetes mellitus.J Pak Med Assoc. 1977 Mar;27(3):293-5. J Pak Med Assoc. 1977. PMID: 409862 Clinical Trial.
-
[Clinical evaluation of glipizide. Results of a multicentric study in Spain].Rev Iber Endocrinol. 1975 Jan-Feb;22(127):43-60. Rev Iber Endocrinol. 1975. PMID: 1145006 Spanish.
-
Clinical evaluation of a new sulfonylurea in maturity onset diabetes - glipizide (K-4024).Horm Metab Res. 1976 Mar;8(2):89-91. Horm Metab Res. 1976. PMID: 770300 Clinical Trial.
-
Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.Clin Pharm. 1984 Sep-Oct;3(5):473-85. Clin Pharm. 1984. PMID: 6435940 Review.
-
Glipizide: a review of its pharmacological properties and therapeutic use.Drugs. 1979 Nov;18(5):329-53. doi: 10.2165/00003495-197918050-00001. Drugs. 1979. PMID: 389600 Review.